Correlation Between Entheon Biomedical and Pharmather Holdings

Can any of the company-specific risk be diversified away by investing in both Entheon Biomedical and Pharmather Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Entheon Biomedical and Pharmather Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Entheon Biomedical Corp and Pharmather Holdings, you can compare the effects of market volatilities on Entheon Biomedical and Pharmather Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Entheon Biomedical with a short position of Pharmather Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Entheon Biomedical and Pharmather Holdings.

Diversification Opportunities for Entheon Biomedical and Pharmather Holdings

-0.03

Correlation Coefficient

Entheon Biomedical  Pharmather Holdings

Good diversification

The 3 months correlation between Entheon and Pharmather is -0.03. Overlapping area represents the amount of risk that can be diversified away by holding Entheon Biomedical Corp and Pharmather Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pharmather Holdings and Entheon Biomedical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Entheon Biomedical Corp are associated (or correlated) with Pharmather Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pharmather Holdings has no effect on the direction of Entheon Biomedical i.e., Entheon Biomedical and Pharmather Holdings go up and down completely randomly.

Pair Corralation between Entheon Biomedical and Pharmather Holdings

Assuming the 90 days horizon Entheon Biomedical Corp is expected to generate 4.22 times more return on investment than Pharmather Holdings. However, Entheon Biomedical is 4.22 times more volatile than Pharmather Holdings. It trades about 0.07 of its potential returns per unit of risk. Pharmather Holdings is currently generating about 0.03 per unit of risk. If you would invest  13.00  in Entheon Biomedical Corp on December 30, 2024 and sell it today you would lose (4.40) from holding Entheon Biomedical Corp or give up 33.85% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	98.41%
Values	Daily Returns

Entheon Biomedical Corp  vs.  Pharmather Holdings

Entheon Biomedical Corp

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Entheon Biomedical Corp are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak fundamental drivers, Entheon Biomedical reported solid returns over the last few months and may actually be approaching a breakup point.

Pharmather Holdings

Risk-Adjusted Performance

Very Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Pharmather Holdings are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite nearly conflicting basic indicators, Pharmather Holdings may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Pair Trading with Entheon Biomedical and Pharmather Holdings

The main advantage of trading using opposite Entheon Biomedical and Pharmather Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Entheon Biomedical position performs unexpectedly, Pharmather Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pharmather Holdings will offset losses from the drop in Pharmather Holdings' long position.

The idea behind Entheon Biomedical Corp and Pharmather Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.